Literature DB >> 31866305

Strategies for Engineering and Rewiring Kinase Regulation.

James W McCormick1, David Pincus2, Orna Resnekov3, Kimberly A Reynolds4.   

Abstract

Eukaryotic protein kinases (EPKs) catalyze the transfer of a phosphate group onto another protein in response to appropriate regulatory cues. In doing so, they provide a primary means for cellular information transfer. Consequently, EPKs play crucial roles in cell differentiation and cell-cycle progression, and kinase dysregulation is associated with numerous disease phenotypes including cancer. Nonnative cues for synthetically regulating kinases are thus much sought after, both for dissecting cell signaling pathways and for pharmaceutical development. In recent years advances in protein engineering and sequence analysis have led to new approaches for manipulating kinase activity, localization, and in some instances specificity. These tools have revealed fundamental principles of intracellular signaling and suggest paths forward for the design of therapeutic allosteric kinase regulators.
Copyright © 2019 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  allostery; coevolution; kinase; optogenetics; phosphoregulation; sector

Mesh:

Substances:

Year:  2019        PMID: 31866305     DOI: 10.1016/j.tibs.2019.11.005

Source DB:  PubMed          Journal:  Trends Biochem Sci        ISSN: 0968-0004            Impact factor:   13.807


  9 in total

Review 1.  ERK signalling: a master regulator of cell behaviour, life and fate.

Authors:  Hugo Lavoie; Jessica Gagnon; Marc Therrien
Journal:  Nat Rev Mol Cell Biol       Date:  2020-06-23       Impact factor: 94.444

2.  Synthetic Reprogramming of Kinases Expands Cellular Activities of Proteins.

Authors:  Veronika M Shoba; Dhanushka N P Munkanatta Godage; Santosh K Chaudhary; Arghya Deb; Sachini U Siriwardena; Amit Choudhary
Journal:  Angew Chem Int Ed Engl       Date:  2022-05-31       Impact factor: 16.823

3.  A zebrafish pparγ gene deletion reveals a protein kinase network associated with defective lipid metabolism.

Authors:  Yan Zhao; L Filipe C Castro; Óscar Monroig; Xiaojuan Cao; Yonghua Sun; Jian Gao
Journal:  Funct Integr Genomics       Date:  2022-03-15       Impact factor: 3.674

Review 4.  Basic and Preclinical Research for Personalized Medicine.

Authors:  Wanda Lattanzi; Cristian Ripoli; Viviana Greco; Marta Barba; Federica Iavarone; Angelo Minucci; Andrea Urbani; Claudio Grassi; Ornella Parolini
Journal:  J Pers Med       Date:  2021-04-29

5.  Reprogramming signal transduction through a designer receptor tyrosine kinase.

Authors:  Tatphon Kongkrongtong; Yuka Sumigama; Teruyuki Nagamune; Masahiro Kawahara
Journal:  Commun Biol       Date:  2021-06-17

6.  Activation of neurotrophin signalling with light‑inducible receptor tyrosine kinases.

Authors:  Wei Zhang; Shu Zhao; Linjie Lu; Zhimin Fan; Shixin Ye
Journal:  Mol Med Rep       Date:  2022-01-11       Impact factor: 2.952

Review 7.  The emergence of molecular systems neuroscience.

Authors:  Yang Shen; Alessandro Luchetti; Giselle Fernandes; Won Do Heo; Alcino J Silva
Journal:  Mol Brain       Date:  2022-01-04       Impact factor: 4.399

8.  Engineered Bacteriorhodopsin May Induce Lung Cancer Cell Cycle Arrest and Suppress Their Proliferation and Migration.

Authors:  Chui-Wei Wong; Ling-Ning Ko; Hung-Jin Huang; Chii-Shen Yang; Shan-Hui Hsu
Journal:  Molecules       Date:  2021-12-03       Impact factor: 4.411

9.  Engineered kinases as a tool for phosphorylation of selected targets in vivo.

Authors:  Katarzyna Lepeta; Chantal Roubinet; Milena Bauer; M Alessandra Vigano; Gustavo Aguilar; Oguz Kanca; Amanda Ochoa-Espinosa; Dimitri Bieli; Clemens Cabernard; Emmanuel Caussinus; Markus Affolter
Journal:  J Cell Biol       Date:  2022-09-14       Impact factor: 8.077

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.